| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |